Paper211586
Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries.
Betz AL and 1 other. Science, 1978. Cited by 288 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries. Papers, record 211586. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/211586
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminoisobutyric Acids | Major topic |
| Blood-Brain Barrier | Major topic |
| Capillary Permeability | Major topic |
| Cerebral Cortex | Major topic |
| Leucine | Major topic |
| Animals | |
| Biological Transport, Active | |
| Cell Membrane | |
| Endothelium | |
| In Vitro Techniques | |
| Rats | |
| Sodium | |
| Sodium-Potassium-Exchanging ATPase |
Source PubMed
Cited by67
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 288 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40498714 | Saturation kinetics and specificity of transporters for L-arginine and asymmetric dimethylarginine (ADMA) at the blood-brain and blood-CSF barriers. | PLoS One | 2025 | https://conductscience.org/library/papers/40498714 | PubMed |
| 40215558 | The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player. | Pharmacol Rev | 2025 | https://conductscience.org/library/papers/40215558 | PubMed |
| 39935212 | Endothelial Cells and the Blood-Brain Barrier: Critical Determinants of Ineffective Reperfusion in Stroke. | Eur J Neurosci | 2025 | https://conductscience.org/library/papers/39935212 | PubMed |
| 38730081 | Unraveling the Role of the Blood-Brain Barrier in the Pathophysiology of Depression: Recent Advances and Future Perspectives. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/38730081 | PubMed |
| 37836018 | Recent Advancements and Strategies for Overcoming the Blood-Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma. | Polymers (Basel) | 2023 | https://conductscience.org/library/papers/37836018 | PubMed |
| 37822873 | Universal method for the isolation of microvessels from frozen brain tissue: A proof-of-concept multiomic investigation of the neurovasculature. | Brain Behav Immun Health | 2023 | https://conductscience.org/library/papers/37822873 | PubMed |
| 37732312 | Development of circadian neurovascular function and its implications. | Front Neurosci | 2023 | https://conductscience.org/library/papers/37732312 | PubMed |
| 37209923 | Mechanisms of cerebrospinal fluid and brain interstitial fluid production. | Neurobiol Dis | 2023 | https://conductscience.org/library/papers/37209923 | PubMed |
| 37111752 | Endocrine Regulation of Microvascular Receptor-Mediated Transcytosis and Its Therapeutic Opportunities: Insights by PCSK9-Mediated Regulation. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37111752 | PubMed |
| 36973040 | ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery. | Pharmacol Rev | 2023 | https://conductscience.org/library/papers/36973040 | PubMed |
| 35997440 | Disturbance of Key Cellular Subproteomes upon Propofol Treatment Is Associated with Increased Permeability of the Blood-Brain Barrier. | Proteomes | 2022 | https://conductscience.org/library/papers/35997440 | PubMed |
| 35456571 | Experimental Comparison of Primary and hiPS-Based In Vitro Blood-Brain Barrier Models for Pharmacological Research. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35456571 | PubMed |
| 35011695 | The Blood-Brain Barrier, an Evolving Concept Based on Technological Advances and Cell-Cell Communications. | Cells | 2021 | https://conductscience.org/library/papers/35011695 | PubMed |
| 34834200 | Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34834200 | PubMed |
| 34831245 | Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer's Disease. | Cells | 2021 | https://conductscience.org/library/papers/34831245 | PubMed |
| 32979312 | Neuronal Activity Regulates Blood-Brain Barrier Efflux Transport through Endothelial Circadian Genes. | Neuron | 2020 | https://conductscience.org/library/papers/32979312 | PubMed |
| 32723840 | Blood-brain barrier: mechanisms governing permeability and interaction with peripherally acting μ-opioid receptor antagonists. | Reg Anesth Pain Med | 2020 | https://conductscience.org/library/papers/32723840 | PubMed |
| 32625502 | Guidance on the risk assessment of substances present in food intended for infants below 16 weeks of age. | EFSA J | 2017 | https://conductscience.org/library/papers/32625502 | PubMed |
| 31671721 | Structure and Junctional Complexes of Endothelial, Epithelial and Glial Brain Barriers. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31671721 | PubMed |
| 31040827 | Nutrient Sensing by Hypothalamic Tanycytes. | Front Endocrinol (Lausanne) | 2019 | https://conductscience.org/library/papers/31040827 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/211586
GET https://conductscience.org/api/papers/v1/211586/cited_by?page=2